Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Palliative Care
  •  Central Nervous System Tumors
  •  Urological Cancers
  •  Bladder Cancer
  •  Targeted Therapy
  •  Radiation Oncology
  •  Head and Neck Oncology
  •  Radiological Techniques and Scans

Abstract

Citation: Clin Oncol. 2016;1(1):1152.DOI: 10.25107/2474-1663.1152

Could Detailed Alk-Status Reporting Help Better Understand Therapy Response to Crizotinib?

Maximilian von Laffert, Florian Alius, Ergin Kilic, Manuela Gerhold, Dido Lenze, Albrecht Stenzinger, Bettina Temmesfeld Wollbrück, Manfred Dietel, Norbert Suttorp, Jens-Carsten Rückert, Jens Neudecker, Mahmoud Ismail, Nikolaj Frost, Michael Hummel, Antje Tessmer and Frederick Klauschen

Department of Pathology, Humboldt University Berlin, Germany
Department of Internal Medicine/Infectious Diseases, Charité, Medical School, Germany
Department of Pathology, University of Heidelberg, Germany
Department of General, Visceral, Vascular and Thoracic Surgery, Universitatsmedizin Berlin, Germany

*Correspondance to: Frederick Klauschen 

 PDF  Full Text Case Series | Open Access

Abstract:

Anaplastic lymphoma kinase (ALK) rearrangements have been found to be actionable mutations in non-small cell lung cancer (NSCLC). ALK-tyrosine kinase inhibitors (TKI) showed very promising therapy response rates and extended progression free survival. We report on three patients, each with an unequivocal ALK-positive status on the protein and genetic level. Two patients show a good response to ALK-inhibition whereas one patient is a non-responder. The latter displayed an unequivocal ALK-positive pattern by immunohistochemistry (IHC) and FISH (fluorescence insitu hybridization), the latter with an additional copy number gain (CNG) of the 3´signal. To date, CNG-patterns were reported as contributors to acquired crizotinib resistance only. Despite the anecdotal character, our report might suggest that this kind of ALK-FISH pattern also plays a role in the context of intrinsic resistance.

Keywords:

Anaplastic lymphoma kinase; Non-small cell lung cancer; Fluorescence in situ hybridization; Immunohistochemistry; Intrinsic resistance; Acquired resistance

Cite the Article:

von Laffert M, Alius F, Kilic E, Gerhold M, Lenze D, Stenzinger A, et al. Could Detailed Alk-Status Reporting Help Better Understand Therapy Response to Crizotinib? Clin Oncol. 2016; 1: 1152.

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

The Expression and Relationship of Tc17 Cells and Interleukin-27 in Local and Systemic Environment of Nonsmall Cell Lung Cancer
 Abstract  PDF  Full Text
A Comprehensive Study of ROS1 Fusion in Patients with Non-Small-Cell Lung Cancer Using Novel ROS1 Immunohistochemistry Clone (SP384)
 Abstract  PDF  Full Text
View More...